Clinical disorders of magnesium metabolism

Comprehensive Therapy

Volumn 23, Issue 3, 1997, Pages 168-173

  Whang, Robert ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b Pacific Islands Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM MAGNESIUM HYDROXIDE; ANTACID AGENT; ANTIBIOTIC AGENT; CARBENICILLIN; CISPLATIN; CYCLOSPORIN; DIGITALIS; DIURETIC AGENT; GENTAMICIN; MAGNESIUM; MAGNESIUM CHLORIDE; MAGNESIUM OXIDE; MAGNESIUM SULFATE; MYLANTA; PENTAMIDINE; TICARCILLIN;

ACUTE INTERMITTENT PORPHYRIA; CARDIOVASCULAR DISEASE; DRUG INDUCED DISEASE; ELECTROLYTE DISTURBANCE; ELECTROLYTE METABOLISM; ENDOCRINE DISEASE; EXCHANGE BLOOD TRANSFUSION; GASTROINTESTINAL DISEASE; HEMODIALYSIS; HUMAN; HYPERMAGNESEMIA; HYPOMAGNESEMIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PREVALENCE; REVIEW;

CARDIOVASCULAR DISEASES; ELECTROLYTES; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; METABOLIC DISEASES; POTASSIUM DEFICIENCY;

EID: 0030964889     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Whang R, Aikawa JK, Oei TO, Hauiter T. Routine serum magnesium determination: an unrecognized need. In: M Cantin, MS Seelig, eds. Magnesium in Health and Disease. New York, NY: SP Medical and Scientific Books. 1980;1-5.
2. Whang R. Routine serum magnesium determination: a continuing unrecognized need. Magnesium. 1987;6:1-4.
3. Whang R, Whang DD, Ryder KW, Oei Tjien O. Routine serum magnesium determination: a contemporary clinical imperative. Magnes Res. 1990;3:267-270.
4. Whang R, Aikawa JK. Magnesium deficiency and refractoriness to potassium repletion. J Chron Dis. 1977;30:65-68.
5. Whang R, Hampton EM, Whang DD. Magnesium homeostasis and clinical disorders of magnesium deficiency. Ann Pharmacotherapy. 1994;28:220-226.
6. Quamme GA, Dirks JH. The physiology of renal magnesium handling. Renal Physiol. 1986;9: 257-269.
7. Mordes JP. Excess magnesium. Pharm Rev. 1978;29:273-300.
8. Flink FB. Magnesium deficiency: etiology and clinical spectrum. Acta Med Scand Suppl. 1981;647:125-137.
9. Elin RS. Laboratory tests for the assessment of magnesium status in humans. Magnes Trace Elem. 1991-1992;10:60-66.
10. Beigelman PM. Potassium in severe diabetic ketoacidosis. Am J Med. 1973;54:419-420.
11. Whang R. Refractory potassium repletion due to magnesium deficiency. Arch Int Med. 1992; 152:2346.
12. Smith WO, Clark RM, Mohr J, Whang R. Vertical and horizontal nystagmus in magnesium deficiency. So Med J. 1980;73:269.
13. Iseri LT, Allen BJ, Brodsky MA. Magnesium therapy of cardiac arrhythmias in critical care medicine. Magnesium. 1989;8:299-306.
14. Whang R, Chrysant S, Dillard B, Smith W, Fryer A. Hypomagnesemia and hypokalemia in 1000 treated ambulatory hypertensive patients. J Am Coll Nutr. 1982;1:317.
15. Hamed LA, Lindeman RD. Dysphagia an vertical nystagmus in magnesium deficiency. Ann Int Med. 1978;89:222-223.
16. Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia. JAMA. 1990;263: 3063-3064.
17. Ryzen E, Wagers PW, Singer FR, Rude KK. Magnesium deficiency in medical intensive care unit populations. Crit Care Med. 1985;13: 19-21.
18. Whang R, Oei TO, Aikawa JK, Vannatta J, Fry A. Predictors of clinical hypomagnesemia: hypokalemia, hypophosphatemia, hyponatremia and hypocalcemia. Arch Intern Med. 1984; 144:1794-1796.
19. Whang R, Flink EB, Dyckner T, Wester PO, Aikawa JK, Ryan MP. Magnesium depletion as a cause of refractory potassium repletion. Arch Intern Med. 1985;145:1686-1689.
20. Rodrigues M, Solanki DL, Whang R. Refractory potassium repletion due to cisplatinum induced magnesium depletion. Arch Intern. Med. 1989;149:2592-2594.
21. Shah GM, Alvarado P, Kirschenbaum MA. Symptomatic hypocalcemia with renal magnesium wasting associated with pentamidine therapy in a patient with AIDS. Am J Med. 1990;89:380-382.
22. Whang R, Welt LG. Observations in experimental magnesium depletion. J Clin Invest. 1963; 43:305-313.
23. Shine KI, Douglas AM. Magnesium effects on ionic exchange and mechanical function in rate ventricle. Am J Physio. 1974;1:317-324.
24. Ryan MP, Whang R, Yamalis W. Effect of magnesium deficiency on cardiac and skeletal muscle potassium during dietary potassium restriction. Proc Soc Exp Biol Med. 1973;143: 1045-1047.
25. Whang R, Morosi HJ, Rodgers D, Reyes R. The influence of continuing magnesium deficiency on muscle K repletion. J Lab Clin Med. 1967;70: 895-902.
26. Heaton RW. Distribution and function of magnesium within the cell. In: Birch NJ, ed. Magnesium and the Cell. San Diego, CA: Academic Press; 1993:1321-136.
27. Skou JC. The influence of some cation in an adenosine triphosphatase from peripheral nerves. Brochim Biophys Acta. 1957;23:394-401.
28. Schilling K, Boring H, Camme G, Hoppe H. Effect of magnesium dependent cell membrane alterations on the transport of K+ in Ehrlich ascites tumor cells. Acta Biol Med Ger. 1980;39: 177-184.
29. Borchgrevink PC, Ryan MP. The effects of magnesium, ouabain and bumetanide on rubidium uptake in human atrial line. Brit J Pharmacol. 1988;95:614-18.
30. Vandenberg CA. Inward rectification of a potassium channel in cardiac ventricular cells depends on internal magnesium ions. Proc Nat Acad Sci. 1987;84:2560-2564.
31. Flatman PW. The role of magnesium in regulating ion transport. In: Birch NJ, ed. Magnesium and the Cell. San Diego, CA: Academic Press; 1993;196-216.
32. Douben S, Brodsky MA, Whang DD, Whang R. Significance of magnesium in congestive heart failure. Am Heart J. 1996;132:664-671.
33. Gottleib SS, Baruch L, Kukin M, Fisher ML, Packer M. Prognostic importance of the serum magnesium in patients with congestive heart failure. J Am Coll Cardiol. 1990;16:827-831.
34. Iseri LT. Potassium, magnesium and digitalis toxicity. In: Whang R, ed. Potassium: Its Biologic Significance. Boca Raton, FL: CRC Press; 1983:125-135.
35. Mason DT, Zelis R, Lee G, et al. Current concepts and treatment of digitalis toxicity. Am J Cardiol. 1971;27:546-559.
36. Whang R, Oei T, Watanabe A. Frequency of hypomagnesemia in hospital patients receiving digitals. Arch Intern Med. 1985;145:655-656.
37. Njinimbam GCG, Ryder KW, Click MR, Click SJ, Whang R. Identification and treatment of hypomagnesemia and hypokalemia in patients receiving digoxin. Clin Chem. 1990;36:L 575.
38. Iseri LT. Magnesium and cardiac arrhythmias. Magnesium. 1986;5:111-126.
39. Iseri LT, Fairshter RD, Hardemann JC, Brodsky MA. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J. 1985; 110:789.
40. Brodsky MA, Orlov M, et al. Magnesium therapy in new onset atrial fibrillation: a randomized placebo-controlled double-blind study. Am J Cardiol. 1994;73:1227-1229.
41. Iseri LT, Chung P, Tobis J. Magnesium therapy for intractable ventricular tachyarrythmias in normomagnsemic patients. West J Med. 1983;6: 823-828.
42. Seligmann H, Halkin H, Rauchfleish S, et al. Thiamine deficiency in patients with coronary heart failure receiving long-term furosemide therapy: a pilot study. Am J Med. 1991;91:151-155.
43. Zieve L. Influence of magnesium deficiency on the utilization of thiamine. Annals N.Y. Academy of Science. 1969;162:732-743.
44. Gullestad L, Oystein OL, Birkeland K, Falch D, Fagerton H, Kjekhus J. Oral versus intravenous magnesium supplementation in patients with magnesium deficiency. Magnes Trace Elem. 1991-1992;10:11-16.
45. Mordes JP, Swartz R, Arky RA. Extreme hypermagnesemia as a cause of refractory hypotension. Ann Int Med. 1975;83:657-658.
46. Ferdinandus J, Pederson JA, Whang R. Hypermagnesemia as a cause of refractory hypotension, respiratory depression and coma. Arch Intern Med. 1981;141:669-670.